Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

BACKGROUND: Selective cyclooxygenase inhibitors may retard the progression of cancer, but they have enhanced thrombotic potential. We report on cardiovascular adverse events in patients receiving rofecoxib to reduce rates of recurrence of colorectal cancer. METHODS: All serious adverse events that...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Kerr, D, Dunn, J, Langman, M, Smith, J, Midgley, R, Stanley, A, Stokes, J, Julier, P, Iveson, C, Duvvuri, R, McConkey, C
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2007

Eitemau Tebyg

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
gan: Midgley, R, et al.
Cyhoeddwyd: (2010)

VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
gan: Kerr, D, et al.
Cyhoeddwyd: (2008)

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
gan: Midgley, R, et al.
Cyhoeddwyd: (2008)

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
gan: Gray, R, et al.
Cyhoeddwyd: (2007)

Adjuvant therapy of colorectal cancer.
gan: Midgley, R, et al.
Cyhoeddwyd: (2000)

ABC of colorectal cancer: adjuvant therapy.
gan: Midgley, R, et al.
Cyhoeddwyd: (2000)

QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients.
gan: Gray, R, et al.
Cyhoeddwyd: (2004)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
gan: Kerr, D, et al.
Cyhoeddwyd: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
gan: Kerr, D, et al.
Cyhoeddwyd: (2000)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
gan: Midgley, R, et al.
Cyhoeddwyd: (2005)

QUASAR Collaborative Group: a randomised study of adjuvant chemotherapy (CT) vs observation in predominantly stage II colorectal cancer
gan: Kerr, D, et al.
Cyhoeddwyd: (2004)

Rofecoxib Induced Purpura
gan: Dogra Sunil, et al.
Cyhoeddwyd: (2004-01-01)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
gan: Midgley, R, et al.
Cyhoeddwyd: (2005)

The NSAID roller coaster: more about rofecoxib.
gan: Aronson, J
Cyhoeddwyd: (2006)

CAPECITABINE (CAPE) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT TREATMENT OF COLORECTAL CANCER (CRC) FIRST AND FINAL TOXICITY RESULTS FROM THE INTERNATIONAL PHASE III QUASAR2 TRIAL
gan: Midgley, R, et al.
Cyhoeddwyd: (2012)

Rofecoxib, Diclofenac e Indometacina aumentam o risco de doença cardiovascular
gan: Filipa Almada Lobo
Cyhoeddwyd: (2006-11-01)

Simultaneous Determination of Rofecoxib and Tizanidine by HPTLC
gan: Uttam D. Pawar, et al.
Cyhoeddwyd: (2009-01-01)

Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
gan: McQuay Henry J, et al.
Cyhoeddwyd: (2004-07-01)

Rofecoxib-Induced Hepatotoxicity: A Forgotten Complication of the Coxibs
gan: Brian Yan, et al.
Cyhoeddwyd: (2006-01-01)

Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
gan: Edwards, J, et al.
Cyhoeddwyd: (2004)

Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
gan: McQuay Henry J, et al.
Cyhoeddwyd: (2004-02-01)

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
gan: Sacchi Ada, et al.
Cyhoeddwyd: (2010-02-01)

Adjuvant chemotherapy for colorectal cancer.
gan: Kerr, D, et al.
Cyhoeddwyd: (1996)

Rofecoxib improves quality of life in patients with hip or knee osteoarthritis
gan: R Theiler, et al.
Cyhoeddwyd: (2002-10-01)

Single dose oral rofecoxib for acute postoperative pain in adults.
gan: Bulley, S, et al.
Cyhoeddwyd: (2009)

Single dose oral rofecoxib for acute postoperative pain in adults.
gan: Bulley, S, et al.
Cyhoeddwyd: (2009)

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
gan: Barden, J, et al.
Cyhoeddwyd: (2002)

The effect of rofecoxib and diclofenac on blood picture in male patients
gan: Mohammed Z.K. Al-Hayali
Cyhoeddwyd: (2008-12-01)

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
gan: Boyd Kathleen A, et al.
Cyhoeddwyd: (2011-12-01)

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
gan: McQuay Henry J, et al.
Cyhoeddwyd: (2002-06-01)

Immunotherapy for colorectal cancer.
gan: Midgley, R, et al.
Cyhoeddwyd: (2003)

Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach
gan: Rozires P. Leão, et al.
Cyhoeddwyd: (2020-08-01)

Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
Cyhoeddwyd: (2004)

Colorectal cancer.
gan: Nicum, S, et al.
Cyhoeddwyd: (2003)

Colorectal cancer
gan: Nicum, S, et al.
Cyhoeddwyd: (2003)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
gan: Midgley, R, et al.
Cyhoeddwyd: (2013)

Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice
gan: Fran Norflus, et al.
Cyhoeddwyd: (2004-11-01)

Chemotherapy for colorectal cancer.
gan: Nicum, S, et al.
Cyhoeddwyd: (2000)

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion
gan: Gábor B. Brenner, et al.
Cyhoeddwyd: (2020-02-01)

SKIN PERMEATION ENHANCEMENT EFFECTS OF ASCORBIC ACID AND TRIETHYL CITRATE ON ROFECOXIB
gan: MALAY K. DAS, et al.
Cyhoeddwyd: (2008-01-01)